848814-27-7Quetiapine, open ring-UNII-DKL8NTR9Y4DKL8NTR9Y4Quetiapine fumarate impurity F [EP]Methanone, [2-[(2-aminophenyl)thio]phenyl][4-[2-(2-hydroxyethoxy)ethyl]-1-piperazinyl]-Methanone, (2-((2-aminophenyl)thio)phenyl)(4-(2-(2-hydroxyethoxy)ethyl)-1-piperazinyl)-QUETIAPINE FUMARATE IMPURITY F [EP IMPURITY](2-((2-Aminophenyl)sulfanyl)phenyl)(4-(2-(2-hydroxyethoxy)ethyl)piperazin-1-yl)methanoneQUETIAPINE FUMARATE IMPURITY F (EP IMPURITY)[2-[(2-aminophenyl)sulfanyl]phenyl][4-[2-(2-hydroxyethoxy)ethyl]piperazin-1-yl]methanoneRefChem:202808
이름 더 보기
Quetiapine Impurity FQuetiapine Impurity 26Quetiapine Impurity F HClQuetiapine Impurity F(EP)Quetiapine Fumarate EP Impurity FQuetiapine Impurity 23(Quetiapine EP Impurity F)2-(4-chlorophenyl)-N'-(1-methylazepan-4-yl)acetohydrazide
Quetiapine fumarate impurity FQuetiapine EP Impurity F[2-(2-aminophenyl)sulfanylphenyl]-[4-[2-(2-hydroxyethoxy)ethyl]piperazin-1-yl]methanone(2-((2-Aminophenyl)thio)phenyl)(4-(2-(2-hydroxyethoxy)ethyl)piperazin-1-yl)methanoneJPBFGXQLPAVCOY-UHFFFAOYSA-NSCHEMBL2083509[2-(2-amino-phenylsulfanyl)-phenyl]-{4(2-(2-hydroxyethoxy)ethyl]piperazin-1-yl}methanoneMethanone,[2-[(2-aminophenyl)thio]phenyl][4-[2-(2-hydroxyethoxy)ethyl]-1-piperazinyl]-
데이터베이스 식별자
CAS
848814-27-7
PubChem CID
11338588
UNII
DKL8NTR9Y4
EC Number
688-146-7
물성
구조 계산 물성보충 중
XLogP
1.7
극성 표면적
104 Ų
수소 결합 공여자 수
2
수소 결합 수용자 수
6
회전 가능 결합 수
8
무거운 원자 수
28
형식 전하
0
복잡도
474
물리화학적 성질
끓는 점
581.8 · 581.8±50.0 °C(Predicted)
밀도
1.3 · 1.30±0.1 g/cm3(Predicted)
용해도
클로로포름(약간 용해됨), 메탄올(약간 용해됨)
물리적 상태
Sticky Solid
산도 계수 (pKa)
14.41 · 14.41±0.10(Predicted)
색상
연한 노란색에서 밝은 갈색까지
안전 및 규제
안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.
GHS 분류
GHS Classification · 4건
Danger
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
P264, P264+P265, P270, P280, P301+P317, P305+P354+P338, P317, P330, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 3 reports by companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.